Advances and Perspectives in Molecular Tumor Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 225
Special Issue Editor
2. Institut National de la Santé et de la Recherche Médicale, S1121, University of Strasbourg, 67000 Strasbourg, France
Interests: cancer research; melanoma research; cancer stem-like cells; tumor progression; metastasis and recurrence; molecular tumor therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Current tumor therapy research is increasingly focusing on the molecular mechanisms of tumorigenesis, proliferation, and targeted therapy. The role of the tumor microenvironment in tumor growth and therapy has also recently attracted more attention in research and drug development. The ability of the microenvironment to trigger tumor maintenance, progression, and resistance is the main cause for treatment failure and tumor relapse.
Molecular targeted therapies are characterized by their specificity to interfere with key molecules of aberrant signaling pathways, particularly those for tumor growth and survival. To deepen the understanding of the molecular basis of tumor development and explore precisive therapeutic strategies, this Special Issue, “Advances and Perspectives in Molecular Tumor Therapy”, aims to collect the latest original articles and reviews describing the molecular aspects of tumor therapy, including, but not limited to, the following areas:
- tumorigenesis;
- immunotherapy;
- targeted therapy;
- tumor microenvironment;
- anti-cancer drugs.
Dr. Mohamed Hassan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumorigenesis
- immunotherapy
- targeted therapy
- tumor microenvironment
- anti-cancer drugs
